B. Beuselinck

Most-cited papers

1. Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

   B. Beuselinck, P. Wolter, A. Karadimou, R. Elaidi +11 more

   2012British Journal of Cancer111 citations Open access

   Semantic Scholar

   Save

2. Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

   T. van Cann, T. Loyson, A. Verbiest, P. Clement +16 more

   2018Supportive Care in Cancer63 citations Open access

   Semantic Scholar

   Save

3. Macrobenthos monitoring on the Belgian Part of the North Sea in the framework of the OSPAR eutrophication assessment (EUTROF)

   B. Beuselinck, N. Viaene, Annick Van Kenhove, D. van Gansbeke +1 more

   20092 citations

   Semantic Scholar

   Save

4. Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patients

   I. Roodhooft, L. Kinget, G. Mammone, M. Baldewijns +13 more

   2026Genes and Immunity1 citations Open access

   Semantic Scholar

   Save

5. MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors

   G. Mammone, R. Coropciuc, T. Van den Wyngaert, R. Jacobs +10 more

   2026Bone Reports0 citations Open access

   Semantic Scholar

   Save